Lawrence Y C Agodoa

Learn More
BACKGROUND AND METHODS The extent to which renal allotransplantation - as compared with long-term dialysis - improves survival among patients with end-stage renal disease is controversial, because those selected for transplantation may have a lower base-line risk of death. In an attempt to distinguish the effects of patient selection from those of(More)
BACKGROUND Lowering LDL cholesterol with statin regimens reduces the risk of myocardial infarction, ischaemic stroke, and the need for coronary revascularisation in people without kidney disease, but its effects in people with moderate-to-severe kidney disease are uncertain. The SHARP trial aimed to assess the efficacy and safety of the combination of(More)
BACKGROUND Previous studies have suggested that the frequency of cancer is higher in patients with end-stage renal disease (ESRD) than in the general population, but have not established whether this increase is confined to certain cancers or to certain categories of ESRD patients. The aim of this study was to examine the risk of cancer in a large cohort of(More)
Allan J. Collins, MD, Robert N. Foley, MB, Charles Herzog, MD, Blanche Chavers, MD, David Gilbertson, PhD, Areef Ishani, MD, MS, Bertram Kasiske, MD, Jiannong Liu, PhD, Lih-Wen Mau, PhD, Marshall McBean, MD, MSc, Anne Murray, MD, MSc, Wendy St. Peter, PharmD, Haifeng Guo, MS, Sally Gustafson, MS, Qi Li, MS, ShuLing Li, MS, Suying Li, PhD, Yi Peng, MS, Yang(More)
CONTEXT Incidence of end-stage renal disease due to hypertension has increased in recent decades, but the optimal strategy for treatment of hypertension to prevent renal failure is unknown, especially among African Americans. OBJECTIVE To compare the effects of an angiotensin-converting enzyme (ACE) inhibitor (ramipril), a dihydropyridine calcium channel(More)
Renal function measurements were obtained in 1,703 African Americans with presumed hypertensive nephrosclerosis who were screened for entry into the African-American Study of Hypertension and Kidney Disease (AASK). We examined the effect of race on relationships involving renal variables by comparing African Americans enrolled into the AASK with non-African(More)
Allan J. Collins, MD, Robert N. Foley, MB, Charles Herzog, MD, Blanche M. Chavers, MD, David Gilbertson, PhD, Areef Ishani, MD, MS, Bertram L. Kasiske, MD, Jiannong Liu, PhD, Lih-Wen Mau, PhD, Marshall McBean, MD, MSc, Anne Murray, MD, MSc, Wendy St. Peter, PharmD, Haifeng Guo, MS, Qi Li, MS, Shuling Li, MS, Suying Li, PhD, Yi Peng, MS, Yang Qiu, MS, Tricia(More)
BACKGROUND Posttransplant lymphoproliferative disorders (PTLD) still represent a major preoccupation after renal transplantation, even in the most recent years. METHODS We analyzed the incidence, risk, and prognostic factors of PTLD in a cohort of kidney recipients using the United States Renal Data System. RESULTS Among 25,127 Medicare patients(More)